A detailed history of Providence Capital Advisors, LLC transactions in Usana Health Sciences Inc stock. As of the latest transaction made, Providence Capital Advisors, LLC holds 109 shares of USNA stock, worth $4,113. This represents 0.0% of its overall portfolio holdings.

Number of Shares
109
Previous 109 -0.0%
Holding current value
$4,113
Previous $4,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 17, 2023

SELL
$54.42 - $63.48 $367,171 - $428,299
-6,747 Reduced 98.41%
109 $6,000
Q1 2023

May 17, 2023

BUY
$54.42 - $63.48 $358,138 - $417,761
6,581 Added 2393.09%
6,856 $431,000
Q1 2023

May 10, 2023

BUY
$54.42 - $63.48 $9,033 - $10,537
166 Added 152.29%
275 $17,000
Q4 2020

Feb 11, 2021

SELL
$73.72 - $85.86 $9,657 - $11,247
-131 Reduced 54.58%
109 $8,000
Q4 2017

Feb 12, 2018

BUY
$57.6 - $75.6 $13,824 - $18,144
240
240 $18,000

Others Institutions Holding USNA

About USANA HEALTH SCIENCES INC


  • Ticker USNA
  • Exchange NYSE
  • Sector Consumer Defensive
  • Industry Packaged Foods
  • Shares Outstandng 19,198,300
  • Market Cap $725M
  • Description
  • USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted s...
More about USNA
Track This Portfolio

Track Providence Capital Advisors, LLC Portfolio

Follow Providence Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Providence Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Providence Capital Advisors, LLC with notifications on news.